|
EP1877428B1
(en)
|
2005-04-22 |
2011-03-16 |
University of Washington |
Cyanine- chlorotoxin conjugate and method for intra-operative visualization of cancer
|
|
US20090176654A1
(en)
|
2007-08-10 |
2009-07-09 |
Protelix, Inc. |
Universal fibronectin type III binding-domain libraries
|
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
|
US8680019B2
(en)
*
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
|
CA2724384A1
(en)
|
2008-05-15 |
2009-11-19 |
Transmolecular, Inc. |
Treatment of metastatic tumors
|
|
AU2009298131B2
(en)
|
2008-10-02 |
2016-07-14 |
Aptevo Research And Development Llc |
CD86 antagonist multi-target binding proteins
|
|
EP2516467A2
(en)
|
2009-12-23 |
2012-10-31 |
Emergent Product Development Seattle, LLC |
Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof
|
|
US20130089554A1
(en)
|
2009-12-29 |
2013-04-11 |
Emergent Product Development Seattle, Llc |
RON Binding Constructs and Methods of Use Thereof
|
|
JP5858932B2
(ja)
|
2010-02-04 |
2016-02-10 |
モルフォテック, インコーポレイテッド |
クロロトキシンポリペプチドおよびコンジュゲートならびにその使用
|
|
ES2601182T3
(es)
|
2010-05-11 |
2017-02-14 |
Fred Hutchinson Cancer Research Center |
Variantes de clorotoxina, conjugados y métodos para su utilización
|
|
AU2011290751B2
(en)
*
|
2010-08-16 |
2015-08-13 |
Pieris Ag |
Binding proteins for Hepcidin
|
|
JP6400470B2
(ja)
|
2011-05-16 |
2018-10-03 |
ジェネロン(シャンハイ)コーポレイション リミテッド |
多重特異性Fab融合タンパク質および使用法
|
|
IN2014MN02293A
(cg-RX-API-DMAC10.html)
|
2012-04-20 |
2015-08-07 |
Emergent Product Dev Seattle |
|
|
SG11201504600UA
(en)
*
|
2012-12-10 |
2015-07-30 |
Hutchinson Fred Cancer Res |
Methods for screening
|
|
ES2786253T3
(es)
|
2013-03-14 |
2020-10-09 |
Immusoft Corp |
Métodos para la diferenciación y transducción in vitro de células b de memoria con vectores virales pseudotipados vsv-g
|
|
EP3027204B1
(en)
|
2013-07-29 |
2022-01-05 |
2seventy bio, Inc. |
Multipartite signaling proteins and uses thereof
|
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
|
US20160250258A1
(en)
|
2013-10-31 |
2016-09-01 |
Fred Hutchinson Cancer Research Center |
Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
|
|
NZ759969A
(en)
|
2013-12-20 |
2022-12-23 |
Fred Hutchinson Cancer Center |
Tagged chimeric effector molecules and receptors thereof
|
|
EP3102224B1
(en)
*
|
2013-12-20 |
2019-02-20 |
NephroGenesis, LLC. |
Apparatuses for kidney dialysis and lipocalin protein for use in the prevention or treatment of uremia by dialysis
|
|
JP5866053B1
(ja)
*
|
2014-12-15 |
2016-02-17 |
株式会社ファンケル |
皮膚粘弾性のマーカー及びその利用
|
|
EP4177336A1
(en)
|
2014-12-19 |
2023-05-10 |
Immusoft Corporation |
B cells for in vivo delivery of therapeutic agents
|
|
SG11201707182WA
(en)
|
2015-03-05 |
2017-10-30 |
Hutchinson Fred Cancer Res |
Immunomodulatory fusion proteins and uses thereof
|
|
EP3288569A4
(en)
|
2015-04-29 |
2018-12-19 |
Fred Hutchinson Cancer Research Center |
Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
|
|
EP3288570A4
(en)
|
2015-04-29 |
2018-11-21 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
|
HK1251480A1
(zh)
|
2015-09-21 |
2019-02-01 |
Aptevo Research And Development Llc |
Cd3结合多肽
|
|
WO2017157305A1
(en)
|
2016-03-15 |
2017-09-21 |
Generon (Shanghai) Corporation Ltd. |
Multispecific fab fusion proteins and use thereof
|
|
EP4166161B1
(en)
|
2016-04-14 |
2026-03-04 |
Fred Hutchinson Cancer Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
US12048732B2
(en)
|
2016-04-15 |
2024-07-30 |
Blaze Bioscience, Inc. |
Methods of treating breast cancer
|
|
IL268349B2
(en)
|
2017-02-17 |
2024-08-01 |
Hutchinson Fred Cancer Res |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
|
US11725210B2
(en)
|
2017-03-17 |
2023-08-15 |
Fred Hutchinson Cancer Center |
Immunomodulatory fusion proteins and uses thereof
|
|
CA3084551A1
(en)
|
2017-12-14 |
2019-06-20 |
Bluebird Bio, Inc. |
Daric interleukin receptors
|
|
EP3847196A4
(en)
|
2018-09-07 |
2023-01-04 |
ITabMed (HK) Limited |
BISPECIFIC ANTIGEN BINDING PROTEINS AND USES THEREOF
|
|
EP3849565A4
(en)
|
2018-09-12 |
2022-12-28 |
Fred Hutchinson Cancer Research Center |
REDUCTION OF CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
|
|
WO2020123938A1
(en)
|
2018-12-14 |
2020-06-18 |
Bluebird Bio, Inc. |
Dimerizing agent regulated immunoreceptor complexes
|
|
WO2020123947A1
(en)
|
2018-12-14 |
2020-06-18 |
Bluebird Bio, Inc. |
Dimerizing agent regulated immunoreceptor complexes
|
|
WO2020132810A1
(en)
|
2018-12-24 |
2020-07-02 |
Generon (Shanghai) Corporation Ltd. |
Multispecific antigen binding proteins capable of binding cd19 and cd3, and use thereof
|
|
KR20220004751A
(ko)
|
2019-05-04 |
2022-01-11 |
인히브릭스, 인크. |
CLEC12a 결합 폴리펩타이드 및 이의 용도
|
|
WO2020227475A1
(en)
|
2019-05-08 |
2020-11-12 |
Bluebird Bio, Inc. |
Cll-1 targeted immunotherapies
|
|
BR112021026832A2
(pt)
|
2019-07-02 |
2022-05-10 |
Hutchinson Fred Cancer Res |
Vetores ad35 recombinantes e aprimoramentos da terapia gênica relacionada
|
|
CN116096754A
(zh)
|
2020-05-04 |
2023-05-09 |
免疫里森公司 |
前体三特异性抗体构建体及其使用方法
|
|
CN111979249B
(zh)
*
|
2020-07-28 |
2021-12-10 |
复旦大学附属眼耳鼻喉科医院 |
一种特异性结合脂质运载蛋白-1的核酸适配体及其应用
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025245169A1
(en)
|
2024-05-21 |
2025-11-27 |
Fred Hutchinson Cancer Center |
Immunotherapy cells equipped with a collagen-targeting payload
|